Literature DB >> 10510243

Identification of target genes of oncogenic transcription factors.

K E Boyd1, P J Farnham.   

Abstract

Disregulation of many transcription factors is associated with the development of human neoplasia. Transcription factors regulate cell growth, differentiation, and apoptosis by binding to specific DNA sequences within the promoter regions of growth-regulatory genes and modulating expression of these genes. This simple model is complicated by the fact that mammalian transcription factors are often members of large protein families that bind to similar DNA sequences. This raises the question as to whether members of a particular family regulate expression of overlapping or unique sets of genes. This review is focused on addressing this question using the Ets, Myc, and E2F transcription factor families as examples. Deregulated activity of some, but not all, members of these families is observed in cancer. Here, we summarize the data illustrating the concept that binding of individual members of these families of factors can result in promoter-specific responses and review the studies that have provided some insight into how target gene specificity is achieved. Since, for all of these oncogenic transcription factors, it remains unclear exactly which target genes are important in neoplasia, we have also reviewed the many approaches researchers are using to identify target genes of the various Ets, Myc, and E2F family members.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510243     DOI: 10.1111/j.1525-1373.1999.09992.x

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  10 in total

1.  Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1.

Authors:  Omar Moussa; Amanda C LaRue; Romeo S Abangan; Christopher R Williams; Xian K Zhang; Masahiro Masuya; Yong Z Gong; Demetri D Spyropoulos; Makio Ogawa; Gary Gilkeson; Dennis K Watson
Journal:  Mol Cell Biol       Date:  2010-09-07       Impact factor: 4.272

2.  Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis.

Authors:  Amy S Weinmann; Pearlly S Yan; Matthew J Oberley; Tim Hui-Ming Huang; Peggy J Farnham
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

3.  Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions.

Authors:  Muhammad G Kibriya; Farzana Jasmine; Maria Argos; Wendy J Verret; Muhammad Rakibuz-Zaman; Alauddin Ahmed; Faruque Parvez; Habibul Ahsan
Journal:  Toxicol Lett       Date:  2007-01-19       Impact factor: 4.372

Review 4.  MYC in breast tumor progression.

Authors:  Yinghua Chen; Olufunmilayo I Olopade
Journal:  Expert Rev Anticancer Ther       Date:  2008-10       Impact factor: 4.512

5.  Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.

Authors:  Ainhoa Iglesias; Matilde Murga; Usua Laresgoiti; Anouchka Skoudy; Irantzu Bernales; Asier Fullaondo; Bernardino Moreno; José Lloreta; Seth J Field; Francisco X Real; Ana M Zubiaga
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

6.  A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.

Authors:  Marius S Pop; Nicolas Stransky; Colin W Garvie; Jean-Philippe Theurillat; Emily C Hartman; Timothy A Lewis; Cheng Zhong; Elizabeth K Culyba; Fallon Lin; Douglas S Daniels; Raymond Pagliarini; Lucienne Ronco; Angela N Koehler; Levi A Garraway
Journal:  Mol Cancer Ther       Date:  2014-04-15       Impact factor: 6.261

7.  Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.

Authors:  Farhan Khan; Luisel J Ricks-Santi; Rabia Zafar; Yasmine Kanaan; Tammey Naab
Journal:  Ann Diagn Pathol       Date:  2018-04-05       Impact factor: 2.090

8.  Evidence that the Nijmegen breakage syndrome protein, an early sensor of double-strand DNA breaks (DSB), is involved in HIV-1 post-integration repair by recruiting the ataxia telangiectasia-mutated kinase in a process similar to, but distinct from, cellular DSB repair.

Authors:  Johanna A Smith; Feng-Xiang Wang; Hui Zhang; Kou-Juey Wu; Kevin Jon Williams; René Daniel
Journal:  Virol J       Date:  2008-01-22       Impact factor: 4.099

Review 9.  Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

10.  Cytotoxic activity of nemorosone in neuroblastoma cells.

Authors:  D Díaz-Carballo; S Malak; W Bardenheuer; M Freistuehler; H P Reusch
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.